Adage Capital Partners
PROK icon

Adage Capital Partners’s ProKidney PROK Stock Holding History

Adage Capital Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,750,000
Closed -$17.4M – 1098
2022
Q2 		$17.4M Hold
1,750,000
– – 0.04% 485
2022
Q1 		$17.3M Hold
1,750,000
– – 0.03% 526
2021
Q4 		$17.3M Hold
1,750,000
– – 0.03% 524
2021
Q3 		$17.1M Hold
1,750,000
– – 0.03% 521
2021
Q2 		$17.7M Buy
+1,750,000
New +$17.7M 0.03% 512

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Adage Capital Partners's PROK Position: Q3 2022 in Review

Adage Capital Partners sold out of ProKidney (PROK) in Q3 2022, closing a stake of 1,750,000 shares — an estimated $17.4M sold.

Adage Capital Partners first reported a position in PROK in Q2 2021 and held it in 5 quarters. The position peaked at $17.7M in Q2 2021. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • Adage Capital Partners reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • Adage Capital Partners sold 1,750,000 ProKidney shares in Q3 2022, an estimated $17.4M.
  • Adage Capital Partners first reported a position in ProKidney in Q2 2021 and held it in 5 quarters.
  • Adage Capital Partners's ProKidney position peaked at $17.7M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Adage Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.